載入...
A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole
BACKGROUND: Aromatase (CYP19A1) regulates estrogen biosynthesis. Polymorphisms in CYP19A1 have been related to the pathogenesis of breast cancer (BC). Inhibition of aromatase with letrozole constitutes the best option for treating estrogen-dependent BC in postmenopausal women. We evaluate a series o...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2830181/ https://ncbi.nlm.nih.gov/pubmed/20144226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-36 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|